Mr. Sebastian Wahl reports

A-LABS CAPITAL II CORP. ANNOUNCES ADOPTION OF SEMI-ANNUAL REPORTING

A-Labs Capital II Corp. is adopting semi-annual financial reporting. This news release is being filed pursuant to Coordinated Blanket Order 51-933, Exemptions to Permit Semi-Annual Reporting for Certain Venture Issuers.

CBO 51-933 allows eligible venture issuers to voluntarily move from a quarterly to a semi-annual financial reporting framework. A-Labs' fiscal year ends on Dec. 31. Under the provisions of CBO 51-933, A-Labs will be exempt from the requirements to file its three-month interim financial statements and associated management's discussion and analysis (MD&A) as it meets the eligibility criteria under CBO 51-933, which include being a venture issuer with annual revenues of less than $10-million and maintaining a clean 12-month continuous disclosure record. Accordingly, A-Labs will not be filing its interim financial statements for the three-month period ending March 31, 2026, and associated MD&A.

A-Labs will continue to file audited annual financial statements (due within 120 days of Dec. 31, 2026) and six-month interim financial reports (due within 60 days of June 30, 2026). A-Labs remains committed to timely disclosure and will continue to report all material changes and significant developments as required under National Instrument 51-102, Continuous Disclosure Obligations.

About A-Labs Capital II Corp.

A-Labs Capital II is a Canadian capital pool company focused on identifying and evaluating assets or businesses with a view to completing a qualifying transaction. The company seeks to acquire or invest in opportunities across various industries, in accordance with the policies of the TSX Venture Exchange.

We seek Safe Harbor.